MichaelAndrewCzorniakMDMS, FCCP
Pulmonology • Cambridge, MAAsthma & COPD, Critical Care Medicine, Cystic Fibrosis, Pulmonary Vascular Medicine
Senior Director, Global Clinical Leader, Alpha-1 and HAE
Dr. Czorniak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Takeda Pharmaceutical Company
40 Landsdowne St
Cambridge, MA 02139
Summary
- Dr. Michael Czorniak is a pulmonologist based in Cambridge, MA, with subspecialties in asthma & COPD, critical care medicine, cystic fibrosis, and pulmonary vascular medicine. He completed his medical education at Vanderbilt University School of Medicine, followed by an internship, residency, and fellowship at Boston University Medical Center, concluding his training in 1987. His areas of experience include alpha-1 anti-trypsin deficiency, cystic fibrosis, critical care medicine, and pulmonary vascular disease. He has contributed to several publications, with notable research on topics including alpha-1 antitrypsin deficiency and the effects of sildenafil citrate on exercise tolerance, which have been cited multiple times in the medical community.
Education & Training
Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1987- Boston University Medical CenterResidency, Internal Medicine, 1983 - 1985
- Boston University Medical CenterInternship, Internal Medicine, 1982 - 1983
Vanderbilt University School of MedicineClass of 1982
Publications & Presentations
PubMed
- 2 citationsAlpha-1 Antitrypsin Deficiency-Associated Clinical Manifestations and Healthcare Resource Use in the United StatesErnesto Mayen Herrera, Corey Joseph, Emily S. Brouwer, Vivek Gandhi, Michael Czorniak
COPD. 2021-05-26 - 5 citationsAdverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myelomaMartin Kaiser, Meral Beksac, Nina Gulbrandsen, Fredrik Schjesvold, Roman Hájek
Annals of Hematology. 2020-07-01 - 56 citationsSildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable anginaKim Fox, Udho Thadani, Patrick Ma, Stephen D. Nash, Zoe Keating
European Heart Journal. 2003-12-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
